Joshua C. Littlejohn

With a broad base of experience in complex litigation-including securities fraud, corporate governance, whistleblower cases under Dodd-Frank and the False Claims Act, and catastrophic injury and death cases-Josh Littlejohn is a key member of Motley Rice’s securities and corporate governance teams, with experience in cases involving healthcare, technology, and finance.

Josh represents public pension funds, unions and other institutional investors in both federal and state courts. He also represents people with catastrophic personal injuries and corporate whistleblowers. Josh works directly with clients and has been involved in all aspects of the litigation process, including case evaluation, fact and expert discovery, resolution and trial.

Throughout his career Josh has been involved in numerous complex securities matters including serving as lead or co-lead counsel in cases involving Wells Fargo & Company; Alexion Pharmaceuticals; Seagate Technologies; Globe Life; Shoals Technologies Group; Amazon; Wells Fargo & Company; 3D Systems Corporation; St. Jude Medical, Inc.; Omnicare; and numerous others. Along with other Motley Rice lawyers, Josh was South Carolina liaison counsel in a securities fraud class action filed in federal court in the District of South Carolina that settled in 2020 filed by investors against SCANA Corporation over its failed nuclear reactor project. Josh regularly reviews and analyzes new securities fraud, corporate governance, and SEC whistleblower matters on behalf of our clients and the firm.

In addition to securities and personal injury matters, Josh evaluates and litigates violations of the federal False Claims Act and Anti-kickback Statute on behalf of corporate whistleblowers.

Aside from various securities and whistleblower matters, Josh was a part of the Motley Rice negotiating team that helped secure a resolution with a major U.S. auto manufacturer on behalf of Takata airbag victims. Early in his career, Josh worked on discovery in mass tort litigation against large drug manufacturers.

Awards, Accolades & Recognitions

Super Lawyers

2013-2017 South Carolina Super Lawyers Rising Stars list
Securities litigation; Class action/mass torts; General litigation

Lawdragon

2019 Lawdragon 500 Plaintiff Financial Lawyers

Blog Posts

February 9, 2026

The impact of product recalls on shareholder wealth Causes, Not Just Cases

by: Christopher Moriarty

February 26, 2020

Decade in Review: Plaintiffs’ Litigation Highlights Causes, Not Just Cases

by: Joseph F. Rice

July 11, 2019

Corporate disclosure in the age of Twitter: Social media’s impact on pension funds Causes, Not Just Cases

by: Annie E. Kouba

News

May 15, 2026

Federal Court Approves $110 Million Wells Fargo Shareholder Derivative Settlement

by: Motley Rice

April 28, 2025

The history and legacy of Workers’ Memorial Day

by:
M. Nolan Webb